Surgery Partners Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Surgery Partners Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 8062 — Services-General Medical & Surgical Hospitals, NEC
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Brentwood
- Headquarters state / province
- Tennessee
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SGRY
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001638833
- EIN
- 47-3620923
Board of directors
-
Andrew T. Kaplan · DirectorSince 2023
-
Blair E. Hendrix · DirectorSince 2023
-
Brent Turner · DirectorSince 2024
-
Clifford G. Adlerz · DirectorSince 2024
-
John A. Deane · DirectorSince 2024
-
Laura L. Forese · DirectorSince 2025
-
Lloyd H. Dean · DirectorSince 2026
-
Patricia Anne Maryland · DirectorSince 2024
-
T. Devin O'Reilly · DirectorSince 2023
-
Teresa DeLuca · DirectorSince 2024
-
Wayne S. DeVeydt · Director · Exec Chairman of the BoardSince 2023
Director election results
Annual meeting of June 5, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
80.2%
Board connections
5 of this board's directors also sit on 8 other boards.
- via Wayne S. DeVeydt
- via Patricia Anne Maryland
- via Teresa DeLuca
- via Andrew T. Kaplan
- via Teresa DeLuca
- via Lloyd H. Dean
- via Patricia Anne Maryland
- via Lloyd H. Dean
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $143,500
- 1 purchase by 1 insider
- Sold, last 12 months
- $1,284,058
- 12 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Teresa DeLuca Director | Open-market purchase | +10,000 | $14.35 | $143,500 |
| Jun 18, 2026 | Blair E. Hendrix Director | Grant or award | +34,364 | $14.55 | $499,996 |
| Jun 5, 2026 | Blair E. Hendrix Director, 10% owner | Grant or award | +11,670 | $13.71 | $159,996 |
| Jun 5, 2026 | John A. Deane Director | Grant or award | +11,670 | $13.71 | $159,996 |
| Jun 5, 2026 | Laura L. Forese Director | Grant or award | +11,670 | $13.71 | $159,996 |
| Jun 5, 2026 | Clifford G. Adlerz Director | Grant or award | +11,670 | $13.71 | $159,996 |
| Jun 5, 2026 | Lloyd H. Dean Director | Grant or award | +11,670 | $13.71 | $159,996 |
| Jun 5, 2026 | Teresa DeLuca Director | Grant or award | +11,670 | $13.71 | $159,996 |
| Jun 5, 2026 | Brent Turner Director | Grant or award | +11,670 | $13.71 | $159,996 |
| Mar 16, 2026 | Doherty David T Officer (Chief Financial Officer) | Open-market sale | −8,867 | $12.50 | $110,838 |
| Mar 16, 2026 | Jason Eric Evans Officer (Chief Executive Officer) | Open-market sale | −20,400 | $12.47 | $254,388 |
| Mar 13, 2026 | Burkhalter Danielle Officer (Chief Human Resources Officer) | Open-market sale | −3,469 | $12.83 | $44,507 |
| Mar 13, 2026 | Brittenham Marissa Officer (Chief Strategy Officer) | Open-market sale | −3,657 | $12.54 | $45,859 |
| Mar 12, 2026 | Baldock Jennifer Officer (Chief Admin & Dev Officer) | Open-market sale | −5,798 | $13.17 | $76,360 |
| Mar 6, 2026 | Jason Eric Evans Officer (Chief Executive Officer) | Open-market sale | −11,462 | $13.79 | $158,061 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.